The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
about
Interventions for non-metastatic squamous cell carcinoma of the skinManagement of atopic dermatitis: safety and efficacy of phototherapyEpidemiology of basal cell carcinoma: scholarly review.Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasisUVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center.Use of biologic agents in combination with other therapies for the treatment of psoriasisThe long-term efficacy and safety of new biological therapies for psoriasisCiclosporin in psoriasis clinical practice: an international consensus statement.Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.Tanning and skin cancer.New agents for prevention of ultraviolet-induced nonmelanoma skin cancer.Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments.Psoriasis: advances in pathophysiology and management.Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin.A quantitative mass spectrometry-based approach for assessing the repair of 8-methoxypsoralen-induced DNA interstrand cross-links and monoadducts in mammalian cells.Psoriasis comorbidities.From conventional to cutting edge: the new era of biologics in treatment of psoriasis.Mycosis fungoides patient accompanied actinic keratosis, actinic keratosis with squamous cell carcinoma transformation, and porokeratosis after NBUVB therapy - 1st case report and review of the literatureBasal cell carcinoma: evidence-based medicine and review of treatment modalities.Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies.Guidelines for diagnosis, prevention and treatment of hand eczema--short version.Guidelines for diagnosis, prevention and treatment of hand eczema.Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis.Modern aspects of phototherapy for atopic dermatitis.Multiple actinic keratosis, squamous cell carcinoma and basal cell carcinoma occurred after PUVA therapy in a Korean patient.Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.Determination of the minimal phototoxic dose and colorimetry in psoralen plus ultraviolet A radiation therapy.Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years.A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil vs. topical imiquimod for the treatment of actinic keratosis.Safety and Efficacy of Phototherapy in the Management of Eczema.Morphea – selected local treatment methods and their effectiveness.British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.
P2860
Q24236003-97366FFF-51FA-4290-9BF7-406157D5CEBCQ26778443-B33FFE1B-D41C-4045-BD81-E8AC6E205794Q30235834-ED0449F3-3B7E-4BAA-BF8D-F363F92E30DAQ33371653-B3FD388C-FEDF-4611-B0DB-F17E715DA640Q34041797-A7D320B5-8D1D-45FC-A8FA-7AEF99610E08Q34400699-AF3A949A-92B2-4AF7-ABF0-4D590E380DDEQ34553755-4829F20C-62A3-435E-AFE8-12149E6E10F7Q34613199-1202EA33-2F61-4206-8FD2-D3AD57BA2D93Q35759170-F822A2E9-5F41-4284-AD7C-FAD9E2A84ECBQ35943114-51E15887-8897-4345-9601-28C9D7D45F27Q36102406-24B0DC43-BA71-4D9E-A0CA-48AB3AA56798Q36341798-B05786B8-2B06-4DEA-8225-D594DA46281CQ36369396-0F83BC1D-8D7D-4EB8-90BE-0845CDE9D106Q36534231-41DFF0ED-EB13-4CFB-BA4C-060271918D3EQ36995858-AFDC731F-B02B-47E8-B7AE-624C4A1F2E20Q37053020-222B149A-783C-4389-9AA5-BCE0E60538B9Q37056699-E1723D7A-7774-4EE1-8985-1457B315326FQ37084274-2F03D7FB-9A77-4D2C-965E-8882B03774ADQ37131025-70BB991A-183D-4D7A-A417-8F813E2D37F7Q37354775-846A8440-3160-4F1E-8851-639A39D85632Q37877283-D75FED67-4001-40A9-A17C-31BCBC3E5C16Q38120851-0983B4FF-04EF-4F5C-A80A-AB54AD236A0EQ38339846-9086237D-4703-423E-9B38-8C213BF19660Q38374914-522C33C0-CA5B-4F7B-B285-C395E972B40FQ38673099-E94C660B-CFB6-4B35-975D-CFCB1A703350Q40008863-8438174E-9898-4E5D-B577-FDF9262146D1Q42452986-34A92E59-1713-4DF5-BB5C-147C291E5A48Q44666730-ADF1452B-AA14-4A4E-8B0C-83427E93B912Q45839560-3EA168C8-42B1-4501-B4B0-E9A72D073D8AQ46692746-D950EFB4-C5D0-409A-B67E-501957ED53ADQ47577972-9FC04986-CEF8-446F-A461-A994D0296A66Q48478885-2963F557-7030-47C1-B46A-A9CEC4AC1E88Q48529298-DE8895D2-4FB6-4FFC-BE7A-130138658FFBQ50074873-7E75353B-A09B-493D-B0D7-5F7D183EADD0Q50350264-0C5EF039-2889-4ACF-B768-29F1A36404FDQ52818545-1DC29EAD-1358-4DB7-B21C-5BF045675B1F
P2860
The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The increased risk of skin can ...... ultraviolet A: a cohort study.
@en
The increased risk of skin can ...... ultraviolet A: a cohort study.
@nl
type
label
The increased risk of skin can ...... ultraviolet A: a cohort study.
@en
The increased risk of skin can ...... ultraviolet A: a cohort study.
@nl
prefLabel
The increased risk of skin can ...... ultraviolet A: a cohort study.
@en
The increased risk of skin can ...... ultraviolet A: a cohort study.
@nl
P1476
The increased risk of skin can ...... ultraviolet A: a cohort study.
@en
P2093
Robert S Stern
Tamar E C Nijsten
P304
P356
10.1046/J.1523-1747.2003.12350.X
P407
P577
2003-08-01T00:00:00Z
P5875
P6179
1048468907